Skip to Content
Merck
  • Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase.

Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase.

Molecular genetics and metabolism (2012-11-20)
Tyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, Allan M Glanzman, David Adams, Richard S Finkel, Don J Mahuran, Gregory M Pastores, Gihan I Tennekoon, Edwin H Kolodny
ABSTRACT

A 12 year-old female presented with a seven-year history of progressive muscle weakness, atrophy, tremor and fasciculations. Cognition was normal. Rectal biopsy revealed intracellular storage material and biochemical testing indicated low hexosaminidase activity consistent with juvenile-onset G(M2)-gangliosidosis. Genetic evaluation revealed compound heterozygosity with two novel mutations in the hexosaminidase β-subunit (c.512-3 C>A and c.1613+15_1613+18dup). Protein analysis was consistent with biochemical findings and indicated only a small portion of β-subunits were properly processed. These results provide additional insight into juvenile-onset G(M2)-gangliosidoses and further expand the number of β-hexosaminidase mutations associated with motor neuron disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
β-N-Acetylglucosaminidase from Streptococcus pneumoniae, recombinant, expressed in E. coli, buffered aqueous solution
Sigma-Aldrich
β-N-Acetylglucosaminidase from Canavalia ensiformis (Jack bean), ammonium sulfate suspension, ≥10 units/mg protein